Skip to main content
. Author manuscript; available in PMC: 2021 Jul 8.
Published in final edited form as: Int J Gynecol Cancer. 2020 Nov 5;31(1):92–97. doi: 10.1136/ijgc-2020-001718

Table 1.

Clinicodemographic data from patient images reviewed

Patient Characteristic n=20
Age at diagnosis (years, median) 65.5 (36–80)
BMI (kg/m2, median) 28.4 (21.1–41)
ECOG Performance Status
 0 8 (40%)
 1 9 (45%)
 2 1 (5%)
 Unknown 2 (10%)
Baseline CA-125 (U/mL, median) 675 (61–12472)
Stage at diagnosis
 IIIC 17 (85%)
 IVA 2 (10%)
 IVB 1 (5%)
Laparoscopic assessment score (median) 9 (0–14)
Type of TRS
 Primary 5 (26%)
 Interval 14 (74%)
 Unknown* 1
Remaining tumor size at TRS
 R0 15 (79%)
 <1cm 1 (5%)
 ≥1 cm 3 (16%)
 Unknown* 1
*

One patient was lost to follow-up following laparoscopic assessment

BMI=body mass index; ECOG=Eastern Cooperative Oncology Group; TRS=tumor reductive surgery; R0=complete gross resection